Repeat-cycle study of high-dose intravenous (iv) 4162W94 anti-CD4 monoclonal antibody (mAb) in rheumatoid arthritis (RA).

被引：0
|
作者：
Panavi, GS
Choy, EHS
Emery, P
Madden, S
Breedveld, FC
Kraan, MC
Kalden, JR
Rascu, A
Brown, JCC
Johnston, JM
机构：
[1] Guys & Kings Coll Hosp, London, England
[2] Univ Leeds, Leeds, W Yorkshire, England
[3] Leiden Univ Hosp, Leiden, Netherlands
[4] Univ Erlangen Nurnberg, D-8520 Erlangen, Germany
[5] Glaxo Wellcome, Res Triangle Pk, NC USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
139
引用
收藏
页码：S56 / S56
页数：1
相关论文
共 27 条
  • [1] Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial
    Choy, EHS
    Panayi, GS
    Emery, P
    Madden, S
    Breedveld, FC
    Kraan, MC
    Kalden, JR
    Rascu, A
    Brown, JCC
    Rapson, N
    Johnston, JM
    RHEUMATOLOGY, 2002, 41 (10) : 1142 - 1148
  • [2] THE IMPORTANCE OF DOSE AND DOSING REGIMEN OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) IN THE TREATMENT OF RHEUMATOID-ARTHRITIS (RA)
    CHOY, EHS
    PITZALIS, C
    BIJL, JA
    KINGSLEY, GH
    PANAYI, GS
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S129 - S129
  • [3] Effect of a humanised non-depleting anti-CD4 monoclonal antibody (mAb) on synovial fluid (SF) in rheumatoid arthritis (RA).
    Choy, EHS
    Connolly, DJA
    Rapson, N
    Kingsley, GH
    Johnston, JM
    Panayi, GS
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 130 - 130
  • [4] IMMUNOLOGICAL EFFECTS OF HIGH-DOSE ADMINISTRATION OF ANTI-CD4 ANTIBODY IN RHEUMATOID-ARTHRITIS PATIENTS
    GOLDBERG, D
    MOREL, P
    CHATENOUD, L
    BOITARD, C
    MENKES, CJ
    BERTOYE, PH
    REVILLARD, JP
    BACH, JF
    JOURNAL OF AUTOIMMUNITY, 1991, 4 (04) : 617 - 630
  • [5] TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS (RA) WITH A CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY
    MORELAND, LW
    BUCY, RP
    PRATT, PW
    KHAZAELI, MB
    LOBUGLIO, AF
    GHRAYEB, J
    DADDONA, P
    SANDERS, ME
    KILGARIFF, C
    RIETHMULLER, G
    KOOPMAN, WJ
    CLINICAL RESEARCH, 1991, 39 (02): : A309 - A309
  • [6] TREATING RHEUMATOID-ARTHRITIS WITH A NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB)
    MORELAND, LW
    BUCY, RP
    KNOWLES, RW
    WACHOLTZ, MC
    HAVERTY, TP
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 199 - 199
  • [7] TREATING RHEUMATOID-ARTHRITIS WITH A NON-DEPLETING ANTI-CD4 MONOCLONAL-ANTIBODY (MAB)
    MORELAND, LW
    BUCY, RP
    KNOWLES, RW
    WACHOLTZ, MC
    HAVERTY, TP
    KOOPMAN, WJ
    ARTHRITIS AND RHEUMATISM, 1995, 38 (06): : R23 - R23
  • [8] THE AMOUNT OF ANTI-CD4 MONOCLONAL-ANTIBODY (MAB) ENTERING THE RHEUMATOID (RA) JOINT MAY DETERMINE CLINICAL EFFICACY
    CHOY, EHS
    PITZALIS, C
    BILL, JA
    KINGSLEY, GH
    PANAYI, GS
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S39 - S39
  • [9] TREATMENT OF RHEUMATOID-ARTHRITIS WITH SINGLE DOSE OR WEEKLY PULSES OF CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY
    CHOY, EHS
    CHIKANZA, IC
    KINGSLEY, GH
    CORRIGALL, V
    PANAYI, GS
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (02) : 291 - 298
  • [10] A PILOT-STUDY USING AN ANTI-CD4 MONOCLONAL-ANTIBODY (OKT4A) IN RHEUMATOID-ARTHRITIS
    CHATENOUD, L
    GOLDBERG, D
    VIARD, JP
    DAIN, MP
    BACH, JF
    MENKES, CJ
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S106 - S106
123